XML 20 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Tables)
3 Months Ended
May 03, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Assumptions used to Compute Share-Based Compensation Expense
The following table shows the Company’s assumptions used to compute the share-based compensation expense: 
 
 
 
Stock Option Plans
 
 
Stock Purchase Plan
 
 
 
May 3,
 
 
May 4,
 
 
May 3,
 
 
May 4,
 
 
 
2014
 
 
2013
 
 
2014
 
 
2013
 
Weighted-average risk free rate of interest
 
 
2.12
%
 
 
1.02
%
 
 
0.17
%
 
 
0.22
%
Expected volatility
 
 
39
%
 
 
42
%
 
 
25
%
 
 
40
%
Weighted-average expected award life
 
 
6.1 years
 
 
 
6.0 years
 
 
 
1.0 year
 
 
 
1.0 year
 
Dividend yield
 
 
2.0
%
 
 
2.3
%
 
 
2.3
%
 
 
2.4
%
Weighted-average fair value
 
$
14.91
 
 
$
10.98
 
 
$
5.79
 
 
$
6.66
 
Options Granted under Stock Option Plans
The information in the following table covers options granted under the Company’s stock option plans for the thirteen weeks ended May 3, 2014:
 
 
 
 
 
 
 
Weighted-
 
 
 
 
 
Weighted-
 
Average
 
(in thousands, except price per share and
 
 
 
Average
 
Exercise
 
weighted-average term)
 
Shares
 
Term
 
Price
 
Options outstanding at the beginning of the year
 
 
5,668
 
 
 
 
$
22.66
 
Granted
 
 
762
 
 
 
 
 
45.08
 
Exercised
 
 
(469)
 
 
 
 
 
21.27
 
Expired or cancelled
 
 
(7)
 
 
 
 
 
27.97
 
Options outstanding at May 3, 2014
 
 
5,954
 
 
6.96
 
$
25.63
 
Options exercisable at May 3, 2014
 
 
4,037
 
 
5.94
 
$
19.80
 
Options available for future grant at May 3, 2014
 
 
1,719
 
 
 
 
 
 
 
Total Intrinsic Value of Options Exercised
The total intrinsic value of options exercised (the difference between the market price of the Company’s common stock on the exercise date and the price paid by the optionee to exercise the option) is presented below:
 
 
 
Thirteen weeks ended
 
 
 
May 3,
 
May 4,
 
 
 
2014
 
2013
 
Exercised
 
$
11
 
$
5
 
Aggregate Intrinsic Value for Stock Options Outstanding and Exercisable
The aggregate intrinsic value for stock options outstanding and for stock options exercisable (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price of the options, multiplied by the number of in-the-money stock options) is presented below:
 
 
 
Thirteen weeks ended
 
 
 
May 3,
 
May 4,
 
 
 
2014
 
2013
 
Outstanding
 
$
128
 
$
86
 
Outstanding and exercisable
 
$
110
 
$
74
 
Information about Stock Options Outstanding and Exercisable
The following table summarizes information about stock options outstanding and exercisable at May 3, 2014:
 
 
 
Options Outstanding
 
Options Exercisable
 
 
 
 
 
 
Weighted-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average
 
Weighted-
 
 
 
 
Weighted-
 
 
 
 
 
 
Remaining
 
Average
 
 
 
 
Average
 
 
 
Number
 
Contractual
 
Exercise
 
Number
 
Exercise
 
Range of Exercise Prices
 
Outstanding
 
Life
 
Price
 
Exercisable
 
Price
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in thousands, except prices per share and contractual life)
 
$ 9.85 to $15.10
 
 
1,526
 
 
5.38
 
$
12.46
 
 
1,526
 
$
12.46
 
$18.01 to $23.92
 
 
1,546
 
 
5.69
 
$
19.93
 
 
1,542
 
$
19.93
 
$24.04 to $34.24
 
 
2,083
 
 
7.95
 
$
32.22
 
 
966
 
$
31.12
 
$34.27 to $45.08
 
 
799
 
 
9.86
 
$
44.62
 
 
3
 
$
35.27
 
 
 
 
5,954
 
 
6.96
 
$
25.63
 
 
4,037
 
$
19.80
 
Changes in Nonvested Options
Changes in the Company’s nonvested options for the thirteen weeks ended May 3, 2014 are summarized as follows:
 
 
 
 
 
 
Weighted-
 
 
 
 
 
Average Grant
 
 
 
Number of
 
Date Fair Value
 
(in thousands, except price per share)
 
Shares
 
per Share
 
Nonvested at the beginning of the year
 
 
2,173
 
$
30.10
 
Granted
 
 
762
 
 
45.08
 
Vested
 
 
(1,011)
 
 
26.60
 
Expired or cancelled
 
 
(7)
 
 
27.97
 
Nonvested at May 3, 2014
 
 
1,917
 
$
37.91
 
Restricted Shares and Units Activity
Restricted shares and units activity for the thirteen weeks ended May 3, 2014 and May 4, 2013 is summarized as follows:
 
 
 
Number of Shares and Units
 
(in thousands)
 
May 3, 2014
 
May 4, 2013
 
Outstanding at beginning of period
 
 
1,369
 
 
1,564
 
Granted
 
 
298
 
 
326
 
Vested
 
 
(462)
 
 
(460)
 
Cancelled or forfeited
 
 
(28)
 
 
(12)
 
Outstanding at end of period
 
 
1,177
 
 
1,418
 
Aggregate value (in millions)
 
$
42
 
$
35
 
Weighted-average remaining contractual life
 
 
1.54 years
 
 
1.34 years